These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27518323)

  • 1. Intranasal Eutectic Powder of Zolmitriptan with Enhanced Bioavailability in the Rat Brain.
    Khan T; Ranjan R; Dogra Y; Pandya SM; Shafi H; Singh SK; Yadav PN; Misra A
    Mol Pharm; 2016 Sep; 13(9):3234-40. PubMed ID: 27518323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
    Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
    Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
    Yu C; Gu P; Zhang W; Cai C; He H; Tang X
    Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan.
    Patel H; Patel P; Modi N; Shah S; Ghoghari A; Variya B; Laddha R; Baradia D; Dobaria N; Mehta P; Srinivas NR
    Eur J Pharm Sci; 2017 Aug; 106():87-93. PubMed ID: 28549679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
    Girotra P; Singh SK; Kumar G
    Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
    Kaur K; Kaur G
    Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
    Shelke S; Shahi S; Jalalpure S; Dhamecha D
    J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of intranasal C-zolmitriptan assessed by positron emission tomography.
    Yates R; Sörensen J; Bergström M; Antoni G; Nairn K; Kemp J; Långström B; Dane A
    Cephalalgia; 2005 Dec; 25(12):1103-9. PubMed ID: 16305598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.
    Vyas TK; Babbar AK; Sharma RK; Misra A
    J Drug Target; 2005 Jun; 13(5):317-24. PubMed ID: 16199375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
    Abdou EM; Kandil SM; Miniawy HMFE
    Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
    Alhalaweh A; Andersson S; Velaga SP
    Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.
    Dalpiaz A; Marchetti N; Cavazzini A; Pasti L; Velaga S; Gavini E; Beggiato S; Ferraro L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():72-8. PubMed ID: 22743338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
    Jha S; Mishra D
    Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micellar nanocarriers: potential nose-to-brain delivery of zolmitriptan as novel migraine therapy.
    Jain R; Nabar S; Dandekar P; Patravale V
    Pharm Res; 2010 Apr; 27(4):655-64. PubMed ID: 20151180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal zolmitriptan.
    Gawel M; Worthington I
    Expert Opin Pharmacother; 2005 Jun; 6(6):1019-24. PubMed ID: 15952929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.